Trusted Resources: Community Center
A Guide to Understanding MPS VI
MPS VI (Maroteaux-Lamy syndrome) is caused by a recessive gene. There is a one in four chance with every pregnancy that the child will inherit the defective gene from each carrier parent and will be affected with the disease. There is a two in three chance that unaffected brothers and sisters of MPS VI children will be carriers.
MPS VI is a mucopolysaccharide disease known as Maroteaux-Lamy Syndrome. It takes its name from two French Doctors, Dr. Maroteaux and Dr. Lamy, who first described the condition in 1963. MPS VI has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS VI.
BookmarkRelated Content
-
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzy...Cardiovascular involvement is among the ...
-
Disease Burden, Management Patterns and Multidisciplinary Clinical Approaches for Patients With MPS IVA and VI in Se...There is a paucity of real-world epidemi...
-
Paul Harmatz, MDDr. Paul Harmatz is a Professor in Resid...
-
H4B Boston’s Living Rooms of RareIn celebration of Rare Disease Day, H4B ...
-
Oral Treatment for Mucopolysaccharidosis VI: Outcomes of the First Phase Iia Study With OdiparcilMucopolysaccharidosis (MPS) disorders ar...
-
Hunter and Kingston’s StoryI have three sons. Hunter is my oldest, ...
-
A Guide to Understanding MPS VI (Maroteaux-Lamy Syndrome)Mucopolysaccharidosis VI (MPS VI) is a v...
